Altered B-cell signaling in lupus

Autoimmunity Reviews

Volumn 8, Issue 3, 2009, Pages 214-218

  Liu, Kui ^a   Mohan, Chandra ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

B cell; Lupus; Signaling

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD16 ANTIGEN; CD22 ANTIGEN; DIACYLGLYCEROL; INOSITOL 1,4,5 TRISPHOSPHATE; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C GAMMA2; PROTEIN KINASE C;

AUTOIMMUNITY; B LYMPHOCYTE; CELL POPULATION; CELL SURVIVAL; CONGENIC STRAIN; CROSS LINKING; GENETIC ENGINEERING; LYMPHOCYTE; NONHUMAN; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; AUTOIMMUNITY; B-LYMPHOCYTES; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GENE TARGETING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; RESEARCH DESIGN; SIGNAL TRANSDUCTION;

EID: 58149477381     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.048     Document Type: Review

References (40)

1. Nath S.K., Kilpatrick J., and Harley J.B. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 16 6 (2004) 794-800
2. Tsao B.P. The genetics of human systemic lupus erythematosus. Trends Immunol 24 11 (2003) 595-602
3. Vyse T.J., and Kotzin B.L. Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 16 (1998) 261-292
4. Pickering M.C., and Walport M.J. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology 39 2 (2000) 133-141 (Oxford, England)
5. Wakeland E.K., Liu K., Graham R.R., and Behrens T.W. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15 3 (2001) 397-408
6. Nagy G., Koncz A., and Perl A. T- and B-cell abnormalities in systemic lupus erythematosus. Crit Rev Immunol 25 2 (2005) 123-140
7. Crispin J.C., and Tsokos G.C. Novel molecular targets in the treatment of systemic lupus erythematosus. Autoimmun Rev 7 3 (2008) 256-261
8. Gauld S.B., Dal Porto J.M., and Cambier J.C. B cell antigen receptor signaling: roles in cell development and disease. Science 296 5573 (2002) 1641-1642 (New York, NY)
9. Quelle F.W. Cytokine signaling to the cell cycle. Immunol Res 39 1-3 (2007) 173-184
10. Grammer A.C., and Lipsky P.E. B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther 5 Suppl 4 (2003) S22-S27
11. Liossis S.N., Kovacs B., Dennis G., Kammer G.M., and Tsokos G.C. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J Clin Invest 98 11 (1996) 2549-2557
12. Mackay M., Stanevsky A., Wang T., Aranow C., Li M., Koenig S., et al. Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med 203 9 (2006) 2157-2164
13. Zhang J., Roschke V., Baker K.P., Wang Z., Alarcon G.S., Fessler B.J., et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166 1 (2001) 6-10
14. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285 5425 (1999) 260-263 (New York, NY)
15. Floto R.A., Clatworthy M.R., Heilbronn K.R., Rosner D.R., MacAry P.A., Rankin A., et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 11 10 (2005) 1056-1058
16. Blank M.C., Stefanescu R.N., Masuda E., Marti F., King P.D., Redecha P.B., et al. Decreased transcription of the human FCGR2B gene mediated by the - 343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet 117 2-3 (2005) 220-227
17. Enyedy E.J., Mitchell J.P., Nambiar M.P., and Tsokos G.C. Defective FcgammaRIIb1 signaling contributes to enhanced calcium response in B cells from patients with systemic lupus erythematosus. Clin Immunol 101 2 (2001) 130-135 (Orlando, Fla)
18. Flores-Borja F., Kabouridis P.S., Jury E.C., Isenberg D.A., and Mageed R.A. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 52 12 (2005) 3955-3965
19. Cornall R.J., Cyster J.G., Hibbs M.L., Dunn A.R., Otipoby K.L., Clark E.A., et al. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8 4 (1998) 497-508
20. Liossis S.N., Solomou E.E., Dimopoulos M.A., Panayiotidis P., Mavrikakis M.M., and Sfikakis P.P. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J Investig Med 49 2 (2001) 157-165
21. Flores-Borja F., Kabouridis P.S., Jury E.C., Isenberg D.A., and Mageed R.A. Altered lipid raft-associate proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 56 1 (2007) 291-302
22. Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358 9 (2008) 900-909
23. Kozyrev S.V., Abelson A.K., Wojcik J., Zaghlool A., Linga Reddy M.V., Sanchez E., et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 40 2 (2008) 211-216
24. Tuscano J.M., Hsu T.C., McKnight H., Ansari A.A., and Gershwin M.E. Phosphorylation abnormalities: NZB mice exhibit a B-cell signalling defect. J Autoimmun 19 3 (2002) 103-109
25. Wu T., Qin X., Kurepa Z., Kumar K.R., Liu K., Kanta H., et al. Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest 117 8 (2007) 2186-2196
26. Morel L., Croker B.P., Blenman K.R., Mohan C., Huang G., Gilkeson G., et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci U S A 97 12 (2000) 6670-6675
27. Mohan C., Alas E., Morel L., Yang P., and Wakeland E.K. Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J Clin Invest 101 6 (1998) 1362-1372
28. Mohan C., Morel L., Yang P., Watanabe H., Croker B., Gilkeson G., et al. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J Clin Invest 103 12 (1999) 1685-1695
29. Liu K., Liang C., Liang Z., Tus K., and Wakeland E.K. Sle1ab mediates the aberrant activation of STAT3 and Ras-ERK signaling pathways in B lymphocytes. J Immunol 174 3 (2005) 1630-1637
30. Liu K., Li Q.Z., Yu Y., Liang C., Subramanian S., Zeng Z., et al. Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis. Genes Immun 8 8 (2007) 634-645
31. Linker-Israeli M., Deans R.J., Wallace D.J., Prehn J., Ozeri-Chen T., and Klinenberg J.R. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147 1 (1991) 117-123
32. Majeti R., Xu Z., Parslow T.G., Olson J.L., Daikh D.I., Killeen N., et al. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103 7 (2000) 1059-1070
33. Di Cristofano A., Kotsi P., Peng Y.F., Cordon-Cardo C., Elkon K.B., and Pandolfi P.P. Impaired Fas response and autoimmunity in Pten+/- mice. Science 285 5436 (1999) 2122-2125
34. Sato S., Hasegawa M., Fujimoto M., Tedder T.F., and Takehara K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 165 11 (2000) 6635-6643
35. Bolland S., and Ravetch J.V. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13 2 (2000) 277-285
36. Nishimura H., Nose M., Hiai H., Minato N., and Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11 2 (1999) 141-151
37. Mecklenbrauker I., Saijo K., Zheng N.Y., Leitges M., and Tarakhovsky A. Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature 416 6883 (2002) 860-865
38. Miyamoto A., Nakayama K., Imaki H., Hirose S., Jiang Y., Abe M., et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 416 6883 (2002) 865-869
39. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190 11 (1999) 1697-1710
40. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17 4 (2002) 515-524